Poster presented on the Chemical Characterization of Leachables/Extractables from Medical Devices PBL Analytical department recently presented a poster on the Chemical Characterization of Leachables/Extractables from Medical Devices at the Extractables and […]

On March 1, 2016 the International Organization for Standardization published the new edition of the ISO 13485 standard. Previously updated in 2003, the revision places more emphasis on the quality […]

According to a recent Markets and Markets report, the global bioburden testing market is expected to reach $565.6 Million by 2018, and Pacific BioLabs has been listed as one of […]

Now available is the recorded copy of the webinar PBL and Nutek presented in April, "Why Understanding Bioburden and Sterilization is Key to Successful Device Development. You can listen and […]

For anyone in the medical device or pharmaceutical fields, it's important to stay up to date on current Good Good Manufacturing practices.In January, the US FDA published a draft guidance […]

At a basic level, Venture Capital (VC) funding can be described as financing provided to startups or other relatively early-stage business that are perceived to have significant growth potential. VC […]

PBL is offering support to biocompatibility clients through assistance with test and method selection for biocompatibility testing. As regulatory bodies, such as the FDA, push for more complex testing, it […]

The USDA performed an annual facility inspection of PBL on June 11. The inspection went smoothly, with no findings issued. Congratulations to the Pacific BioLabs IACUC and everyone involved. […]

Last week I was privileged to be able to participate in a focus group for California East Bay biomanufacturing.The purpose of the focus group was to generate […]

This year has been somewhat up and down for medical device developers. The medical device excise tax was approved, and any devices sold starting in 2013 will be subject to […]